Manager, Patient Marketing
Blueprint Medicines | |
United States, Massachusetts, Cambridge | |
45 Sidney Street (Show on map) | |
Jan 15, 2025 | |
How will your role help us transform hope into reality? Are you passionate about creating unforgettable experiences that can change lives? Do you thrive on engaging with communities and making a real impact? Blueprint Medicines is seeking a dynamic and innovativePatient Marketing Manager with a deep expertise in Experiential marketing to join our marketing team. In this pivotal role, you will be at the forefront of creating word-of-mouth awareness of systemic mastocytosis (SM) and available treatment options, including AYVAKIT. You will develop and execute engaging and interactive experiences that engage patients and customers, leveraging both live and social sharing platforms to extend the impact of these experiences. Additionally, you will play a key role in our Live Patient Program, fostering direct interactions and support within the patient community. This position offers a unique opportunity to continue building and creating a market for patients who are currently underdiagnosed, ultimately improving their quality of life. As this role is relatively new within Blueprint Medicines and the industry, you will have the chance to shape and define the experiential patient marketing landscape, bringing innovative ideas to life and setting new standards for patient engagement. This position reports to the Sr. Director, Direct to Patient Team Lead. What will you do?
What minimum qualifications do we require?
What additional qualifications will make you a stronger candidate?
Why Blueprint? At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators - the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success. This is the place where the extraordinary becomes reality, and you could be part of it. Patients are waiting. Are you ready to make the leap? Equity, Diversity, Inclusion and Affirmative Action At Blueprint Medicines, we foster a culture of equity, diversity and inclusion. A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law. We are also an E-Verify Employer. We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com. For more information, please see our EEO-AA Policy Statement, the EEO Know Your Rights Poster, as well as our Pay Transparency Statement. Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors. #LI-Hybrid |